Nascent Biotech, Inc. NBIO
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0005 Day range 0.0005
0.0001 52-week range 0.1345
- YTD
- -66.67%
- 1 year
- -91.30%
- Market cap
- 34.44K
- YTD return
- -66.67%
- 1-year return
- -91.30%
- Volume
- 15.00K
- Avg volume
- 22.39K
- Open
- 0.0005
- Previous close
- 0.0002
- Day's range
- 0.0005 – 0.0005
- 52-week range
- 0.0001 – 0.1345
2Y -0.0549 (-99.64%)
News
Nascent Biotech (OTCMKTS:NBIO) Stock Price Crosses Above 50 Day Moving Average – Time to Sell? 
Nascent Biotech Presents at the July Emerging Growth Conference 
Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run 
Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System 
Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates 
Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued 
Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk 
Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier 
Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer 
Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meeting
Your note
Sign in to keep a note on NBIO — it syncs with the Stock Master app.